This filing confirms GSK is steadily executing its existing buyback program. No new authorization or change in pace is indicated. Traders should monitor future 6-K filings for cumulative buyback progress and any updates to the program's size or duration.
Price Chart
Executive Summary
GSK filed a routine 6-K disclosing weekly share repurchases under its existing buyback program. The company bought ~1.1M shares over five days in June 2026 at an average price of ~1,930 GBp, continuing the program announced on May 11, 2026. This is a standard periodic update with no new strategic or financial information.
Key Facts
- Purchased 225,237 shares on June 8, 228,524 on June 9, 222,449 on June 10, 220,242 on June 11, and 215,972 on June 12, 2026.
- Volume-weighted average prices ranged from 1,882.23 GBp to 1,983.00 GBp per share.
- Since May 11, 2026, GSK has repurchased a total of 7,346,236 ordinary shares.
- After these purchases, GSK holds 268,724,522 shares in treasury (6.64% of voting rights) and has 4,047,527,077 shares in issue (excluding treasury).
Financial Impact
Approximately £21.2M spent on repurchases during the reported week (based on VWAP and share counts), representing ~0.02% of market cap. Cumulative program spend since May 11 is not disclosed but is a fraction of the overall buyback authorization.
Risk Factors
- None material from this filing; buyback execution is routine and within announced parameters.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-005975 |
| Document: 0001654954-26-005975-index-headers.html | 0001654954-26-005975 |
| Document: 0001654954-26-005975-index.html | 0001654954-26-005975 |
| Document: 0001654954-26-005975.txt | 0001654954-26-005975 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access